Healthcare >> Sector Roundtables >> January 22, 2001
MARIO V. CORSO, CFA, is a Senior Analyst covering the pharmaceutical and
biotechnology industries since 1996. He was previously associated with
Copley Pharmaceuticals and Scudder Investments. Mr. Corso received a BA
in Economics from the University of Connecticut and an MBA from
Northeastern University. He has earned the Chartered Financial Analyst
(CFA) designation. Profile
LEONARD S. YAFFE is a Pharmaceutical Analyst for Banc of America
Securities, focusing on health care distribution and pharmaceutical
stocks. He was previously associated with Gilford Securities and
Vincent, Chesley & Company. Dr. Yaffe received a BS in Medicine and an
MD, both from Northwestern University Medical School. He is married and
includes baseball, tennis and wine collecting among his interests. Profile
JEFFREY J. KRAWS is a Pharmaceutical Analyst at Gruntal & Company,
L.L.C., focusing on large cap pharmaceutical, specialty pharmaceutical,
drug delivery/distribution systems, biopharmaceutical and medical
technology stocks. He was previously associated with EVEREN Securities,
Bristol-Myers Squibb and Buckingham Research. Mr. Kraws received a BS
from the State University of New York and an MBA from Cornell
University. Profile
D. LARRY SMITH is a Pharmaceuticals Analyst at Sutro & Company, focusing
on pharmaceuticals, physicians management, radiology services and
hospital outsourcing stocks. He was previously associated with Hambrecht
& Quist Smith . Mr. Smith received a BS in Mechanical Engineering at
Purdue University, MS in Mechanical Engineering from Stanford University
and an MBA from Columbia University.
SERGIO C. TRAVERSA is a Pharmaceutical Analyst with ING Barings L.L.C.,
focusing on US and European pharmaceutical stocks. He was previously
associated with Mehta and Isaly and Mehta Partners. Prior to that he was
associated with Farmitalia Carlo Erba, Johnson & Johnson and Eli Lilly.
Mr. Traversa received a Doctor of Pharmacy from the University of Turin
and an MBA from the Stern School of Business at New York University. Profile
TWST: Len, tell us how the predictions that you made at last year's WallStreet Transcript Roundtable have turned out. We should note that at
that time, you described your position as unabashedly